Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905148-25-001772
Filing Date
2025-05-15
Accepted
2025-05-15 16:41:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7181
2 jfa.htm EX-99.1 6995
3 subsidiaries.htm EX-99.2 2916
  Complete submission text file 0000905148-25-001772.txt   18883
Mailing Address 1-13-1 NIHONBASHI CHUO-KU TOKYO M0 103-8645
Business Address 1-13-1 NIHONBASHI CHUO-KU TOKYO M0 103-8645 81-3-5255-1000
NOMURA HOLDINGS INC (Filed by) CIK: 0001163653 (see all company filings)

EIN.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)

Mailing Address 600 W. FULTON STREET, SUITE 800 CHICAGO IL 60661
Business Address 600 W. FULTON STREET, SUITE 800 CHICAGO IL 60661 (312) 929-0993
Cresco Labs Inc. (Subject) CIK: 0001832928 (see all company filings)

EIN.: 981505364 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92428 | Film No.: 25954498
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)